317 episodes

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

PeerVoice Internal Medicine Audio PeerVoice

    • Science
    • 4.5 • 2 Ratings

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

    Marla C. Dubinsky, MD - Most Patients With Ulcerative Colitis ‘Can’t Wait’: The Impact and Clinical Assessment of Bowel Urgency

    Marla C. Dubinsky, MD - Most Patients With Ulcerative Colitis ‘Can’t Wait’: The Impact and Clinical Assessment of Bowel Urgency

    Visit https://www.peervoice.com/EJU860 to view the entire programme with slides. After completing “Marla C. Dubinsky, MD - Most Patients With Ulcerative Colitis ‘Can’t Wait’: The Impact and Clinical Assessment of Bowel Urgency”, participants will be able to: Discuss recent data regarding bowel urgency experienced by patients with UC and the impact on QoL; Describe how bowel urgency is linked to poor clinical outcomes, biomarkers, and disease activity; and Recognise the benefits and limitations of current PRO tools for bowel urgency and create innovative communication techniques based on real-world experience.

    • 51 min
    Anton Pozniak, MD, FRCP - Resistance is Futile: Achieving and Maintaining HIV Viral Suppression

    Anton Pozniak, MD, FRCP - Resistance is Futile: Achieving and Maintaining HIV Viral Suppression

    Visit https://www.peervoice.com/QGC860 to view the entire programme with slides. After completing “Anton Pozniak, MD, FRCP - Resistance is Futile: Achieving and Maintaining HIV Viral Suppression”, participants will be able to: Differentiate between resistance profiles of approved antiretroviral therapies/regimens for HIV; Identify factors that may influence treatment decision-making, help circumvent drug resistance, and optimise outcomes for people living with HIV (PLWH); and Develop individualised treatment regimens for people living with drug-resistant HIV.

    • 50 min
    Paolo Ventura, MD - Perspectives in Acute Hepatic Porphyria Care: Improving Long-Term Management with Novel Therapeutics

    Paolo Ventura, MD - Perspectives in Acute Hepatic Porphyria Care: Improving Long-Term Management with Novel Therapeutics

    Visit https://www.peervoice.com/ZBV860 to view the entire programme with slides. After completing “Paolo Ventura, MD - Perspectives in Acute Hepatic Porphyria Care: Improving Long-Term Management with Novel Therapeutics”, participants will be able to: Summarise key findings from the 24-month analysis of the ENVISION trial in patients with acute hepatic porphyria (AHP); Discuss the current practices and unmet needs for the long-term management of AHP; and Describe the impact of these data on clinical practice within the context of treatment paradigms for the long-term management of patients with AHP.

    • 32 min
    Wytske Fokkens, MD, PhD - Biologics for CRSwNP Management: Your Questions Answered

    Wytske Fokkens, MD, PhD - Biologics for CRSwNP Management: Your Questions Answered

    Visit https://www.peervoice.com/URC860 to view the entire programme with slides. After completing “Wytske Fokkens, MD, PhD - Biologics for CRSwNP Management: Your Questions Answered”, participants will be able to: Evaluate how biologic therapies fit into the treatment paradigm for patients with chronic rhinosinusitis with nasal polyps (CRSwNP); Use patient and disease characteristics to identify patients who may benefit from biologic therapy; and Apply practical strategies for monitoring and managing patients with CRSwNP who are receiving biologic therapy.

    • 21 min
    Aoife Egan, MB, BCh, PhD - Insulin Resistance and Women’s Health: Case Studies in Gestational Diabetes and Polycystic Ovarian Syndrome

    Aoife Egan, MB, BCh, PhD - Insulin Resistance and Women’s Health: Case Studies in Gestational Diabetes and Polycystic Ovarian Syndrome

    Visit https://www.peervoice.com/TTP860 to view the entire programme with slides. After completing “Aoife Egan, MB, BCh, PhD - Insulin Resistance and Women’s Health: Case Studies in Gestational Diabetes and Polycystic Ovarian Syndrome”, participants will be able to: Discuss the importance of therapeutic intervention in patients with insulin resistance and gestational diabetes (GDM) or polycystic ovary syndrome (PCOS); Explain current evidence for anti-hyperglycaemic therapies for the management of patients with GDM and PCOS; and Formulate management plans that optimise long-term outcomes for patients with GDM and PCOS.

    • 41 min
    "Pantelis Sarafidis, MD, MSc, PhD - Meeting the Challenge of Improving Outcomes in CKD and T2DM: A Call to Action for Clinicians "

    "Pantelis Sarafidis, MD, MSc, PhD - Meeting the Challenge of Improving Outcomes in CKD and T2DM: A Call to Action for Clinicians "

    Visit https://www.peervoice.com/XUP860 to view the entire programme with slides. After completing “"Pantelis Sarafidis, MD, MSc, PhD - Meeting the Challenge of Improving Outcomes in CKD and T2DM: A Call to Action for Clinicians
    "”, participants will be able to: Describe the role of nonsteroidal mineralocorticoid receptor antagonists (MRAs) as part of an overall treatment strategy to improve renal and cardiovascular outcomes for patients with chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM); Outline the emerging standards of care for management of patients with CKD and T2DM, based on the “four-pillar” approach; and Explain the rationale for the recent updates in management guidelines for patients with CKD and T2DM.

    • 17 min

Customer Reviews

4.5 out of 5
2 Ratings

2 Ratings

Top Podcasts In Science

Hidden Brain
Alie Ward
Sam Harris
Neil deGrasse Tyson
CBS News Radio
Freakonomics Radio + Stitcher

You Might Also Like

More by PeerVoice

PeerVoice
PeerVoice
PeerVoice
PeerVoice
PeerVoice
PeerVoice